These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 29549023)

  • 21. Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells.
    Grabowski N; Hillaireau H; Vergnaud J; Santiago LA; Kerdine-Romer S; Pallardy M; Tsapis N; Fattal E
    Int J Pharm; 2013 Oct; 454(2):686-94. PubMed ID: 23747506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain.
    Belletti D; Grabrucker AM; Pederzoli F; Menrath I; Vandelli MA; Tosi G; Duskey TJ; Forni F; Ruozi B
    Int J Pharm; 2018 May; 543(1-2):300-310. PubMed ID: 29608954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface modification of PLGA nanoparticles by carbopol to enhance mucoadhesion and cell internalization.
    Surassmo S; Saengkrit N; Ruktanonchai UR; Suktham K; Woramongkolchai N; Wutikhun T; Puttipipatkhachorn S
    Colloids Surf B Biointerfaces; 2015 Jun; 130():229-36. PubMed ID: 25937384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folate-modified PLGA nanoparticles for tumor-targeted delivery of pheophorbide a in vivo.
    Son J; Yang SM; Yi G; Roh YJ; Park H; Park JM; Choi MG; Koo H
    Biochem Biophys Res Commun; 2018 Apr; 498(3):523-528. PubMed ID: 29518390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting.
    Chung YI; Kim JC; Kim YH; Tae G; Lee SY; Kim K; Kwon IC
    J Control Release; 2010 May; 143(3):374-82. PubMed ID: 20109508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
    Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
    Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine-conjugated poly(lactic-co-glycolic acid) nanoparticles for protein delivery to macrophages.
    Lee SY; Cho HJ
    J Colloid Interface Sci; 2017 Mar; 490():391-400. PubMed ID: 27914338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and characterization of negatively charged poly(lactic-co-glycolic acid) microspheres.
    Xu Q; Crossley A; Czernuszka J
    J Pharm Sci; 2009 Jul; 98(7):2377-89. PubMed ID: 19009589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration.
    Tahara K; Miyazaki Y; Kawashima Y; Kreuter J; Yamamoto H
    Eur J Pharm Biopharm; 2011 Jan; 77(1):84-8. PubMed ID: 21074612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spontaneous arrangement of a tumor targeting hyaluronic acid shell on irinotecan loaded PLGA nanoparticles.
    Giarra S; Serri C; Russo L; Zeppetelli S; De Rosa G; Borzacchiello A; Biondi M; Ambrosio L; Mayol L
    Carbohydr Polym; 2016 Apr; 140():400-7. PubMed ID: 26876867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach.
    Girotra P; Singh SK; Kumar G
    Int J Biol Macromol; 2016 Apr; 85():92-101. PubMed ID: 26724690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
    Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
    Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles.
    Yang Y; Xie XY; Mei XG
    Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal and intravenous administration of octa-arginine modified poly(lactic-co-glycolic acid) nanoparticles facilitates central nervous system delivery of loperamide.
    O'Donnell A; Moollan A; Baneham S; Ozgul M; Pabari RM; Cox D; Kirby BP; Ramtoola Z
    J Pharm Pharmacol; 2015 Apr; 67(4):525-36. PubMed ID: 25515568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.